Adequan IM

Name: Adequan IM

Adequan® i.m. MULTI-DOSE

Brand of Polysulfated Glycosaminoglycan (PSGAG)
Solution 100 mg/mL in 20 mL, 30 mL, and 50 mL Preserved Multi-Dose Vials
For Intramuscular Use In Horses Only. Not for Intra-Articular Use.

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Description

Each mL contains Polysulfated Glycosaminoglycan 100 mg, Benzyl Alcohol 0.9% v/v as a preservative, and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH.

Pharmacology

Polysulfated Glycosaminoglycan is chemically similar to the glycosaminoglycans in articular cartilage matrix. PSGAG is a potent proteolytic enzyme inhibitor and diminishes or reverses the pathologic processes of traumatic or degenerative joint disease which result in a net loss of cartilage matrix components. PSGAG improves joint function by reducing synovial fluid protein levels and increasing synovial fluid hyaluronic acid concentration in traumatized equine carpal and hock joints.

Indications

Adequan® i.m. Multi-Dose is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

Storage conditions

Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) (See USP Controlled Room Temperature). Dispose of spent needles in accordance with all federal, state and local environmental laws.

How supplied

Adequan® i.m. Multi-Dose solution, 100 mg/mL is available in 20 mL, 30 mL and 50 mL glass vials, packaged in boxes of 1.

LUITPOLD PHARMACEUTICALS, INC.
Animal Health Division
Shirley, NY 11967
(631) 924-4000
800-458-0163

Made in U.S.A.
IN92901
Rev. 10/08
MG# 28493

NADA #140-901, Approved by FDA

(web3)